Oracle Corp (ORCL)
116.67
+0.03
(+0.03%)
USD |
NYSE |
May 10, 16:00
116.64
-0.03
(-0.03%)
Pre-Market: 04:11
Oracle R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
Date | Value |
---|---|
February 29, 2024 | -- |
November 30, 2023 | -- |
August 31, 2023 | -- |
May 31, 2023 | -- |
February 28, 2023 | -- |
November 30, 2022 | -- |
August 31, 2022 | -- |
May 31, 2022 | -- |
February 28, 2022 | -- |
November 30, 2021 | -- |
August 31, 2021 | -- |
May 31, 2021 | -- |
February 28, 2021 | -- |
November 30, 2020 | -- |
August 31, 2020 | -- |
May 31, 2020 | -- |
February 29, 2020 | -- |
November 30, 2019 | -- |
August 31, 2019 | -- |
May 31, 2019 | -- |
February 28, 2019 | -- |
November 30, 2018 | -- |
August 31, 2018 | -- |
May 31, 2018 | -- |
February 28, 2018 | -- |
Date | Value |
---|---|
November 30, 2017 | -- |
August 31, 2017 | -- |
May 31, 2017 | -- |
February 28, 2017 | -- |
November 30, 2016 | -- |
August 31, 2016 | -- |
May 31, 2016 | -- |
February 29, 2016 | -- |
November 30, 2015 | -- |
August 31, 2015 | -- |
May 31, 2015 | -- |
February 28, 2015 | -- |
November 30, 2014 | -- |
August 31, 2014 | -- |
May 31, 2014 | -- |
February 28, 2014 | -- |
November 30, 2013 | -- |
August 31, 2013 | -- |
May 31, 2013 | -- |
February 28, 2013 | -- |
November 30, 2012 | -- |
August 31, 2012 | -- |
May 31, 2012 | -- |
February 29, 2012 | -- |
November 30, 2011 | -- |
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.